Form 4: ADC Therapeutics Director Peter Hug Reports Routine Share Withholding for Tax Obligations

ADC Therapeutics SA Director Peter Hug reported a routine transaction involving the withholding of 2,144 common shares to cover tax liabilities associated with the vesting of restricted share units.

Summary

• Peter Hug, a Director of ADC Therapeutics SA (ADCT), filed a Form 4 reporting a change in beneficial ownership.
• On June 13, 2025, 2,144 common shares were disposed of (withheld) by the Issuer.
• This transaction was executed at a price of $3.58 per share.
• The shares were withheld to satisfy Mr. Hug's tax withholding obligations in connection with the vesting of previously granted restricted share units (RSUs).
• Following this transaction, Peter Hug beneficially owns 220,500 common shares directly.

Sentiment

Score: 5

Explanation: The sentiment is neutral as this is a routine, non-discretionary transaction for tax purposes related to equity compensation, not indicative of positive or negative company performance or insider sentiment.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.

Industry Context

This Form 4 filing is a standard disclosure for insider transactions, specifically related to tax withholding upon RSU vesting, and does not provide broader industry context or trends. Such transactions are common across all industries for executives and directors receiving equity compensation.

Stakeholder Impact

• Shareholders: Minimal direct impact as this is a small, non-discretionary transaction for tax purposes and does not reflect a change in the director's investment thesis or company outlook.
• Employees: No direct impact mentioned.

Key Dates

Keywords

ADC Therapeutics, ADCT, Peter Hug, Form 4, Insider Transaction, Share Withholding, Restricted Share Units, Tax Obligations, Beneficial Ownership